Sponsor:
Ottawa Heart Institute Research Corporation
Code:
NCT07585175
Conditions
Congenital Heart Disease (CHD)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Multi-pronged transfer program
Brief summary:
Conditions
Congenital Heart Disease (CHD)
Study ID
NCT07585175
Start date
Jun 1, 2024
Status verified date
Jun, 2026
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
200 participants
Anticipated
Arms
Patients with congenital heart disease referred to the University of Ottawa Heart Institute
Interventions
Multi-pronged transfer program
Primary outcome measure
Central contacts
Locations
University of Ottawa Heart Institute
Recruiting
Ottawa, Ontario, Canada, K1Y4W7
Contacts
Keren Mbondo Kasuku, HBSc
kmbondo@ottawaheart.caPrincipal Investigator:
Markus Schwerzmann, MD
Sponsor
Ottawa Heart Institute Research Corporation
Last update posted
Jul 2, 2026
Last verified
Jun, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Ottawa Heart Institute Research Corporation on 2026-07-02.